Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Garvey

Plastic and Reconstructive Surgery Houston, TX Medical Doctor

NPI 1386620490 CMS profile 16989

1515 Holcombe Blvd, Houston, TX 77030

Open in the dashboard

General payments

$116,736

164 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$294,308 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Patrick Garvey of Houston, TX is reported in the CMS Open Payments database as having received $116,736 across 164 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $294,308 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,918 38
2024 General $23,832 19
2023 General $18,138 26
2022 General $1,801 21
2021 General $7,256 10
2020 General $28,997 27
2019 General $11,794 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Garvey
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Patrick Garvey were reported at $24,918. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Patrick Garvey Plastic and Reconstructive Surgery median Middle half National median
2019 $11,794 $335 $121–$1,264 $163
2020 $28,997 $162 $57–$417 $114
2021 $7,256 $245 $89–$735 $132
2022 $1,801 $325 $120–$932 $149
2023 $18,138 $343 $129–$999 $160
2024 $23,832 $390 $141–$1,085 $164
2025 $24,918 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $102,822 91 payments
  2. Medical Device Business Services, Inc. $8,319 3 payments
  3. Mentor Worldwide LLC $1,333 17 payments
  4. Davol Inc. $671 5 payments
  5. DePuy Synthes Sales Inc. $589 9 payments
  6. Sientra, Inc. $501 6 payments
  7. Allergan Inc. $333 4 payments
  8. Baxter Healthcare $317 4 payments
  9. Stryker Corporation $306 4 payments
  10. Musculoskeletal Transplant Foundation Inc. $259 4 payments
  11. Other $1,285 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $42,998 13 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $41,850 6 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $12,713 1 payment
  4. Food and Beverage $11,798 120 payments
  5. Travel and Lodging $7,377 24 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $75,568 49 payments
  2. AXOGUARD NERVE PROTECTOR $71,667 54 payments
  3. AxoGuard Nerve Connector $71,667 54 payments
  4. AXOGUARD HA+ NERVE PROTECTOR Neurology $23,593 18 payments
  5. AXOGUARD Neurology $23,593 18 payments
  6. AXOGUARD NERVE CAP Neurology $23,593 18 payments
  7. AXOGUARD Neurology $23,593 18 payments
  8. AXOGUARD NERVE CAP Neurology $22,967 10 payments
  9. Axoguard HA+ Nerve Protector Neurology $22,967 10 payments
  10. MATRIXMANDIBLE $7,793 4 payments
  11. Other $28,867 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$51,716

Medicare's payments for the services billed

Medicare patients

31

Average age 71

Services billed

112

18 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Chronic kidney disease 42%
Ischemic heart disease 35%
Cancer 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record